Financial Partners Group »

Fs Global Cr Opportunitie Fda shares owned by Financial Partners Group

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Financial Partners Group from 13F filings

Historical chart of Financial Partners Group investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Financial Partners Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Financial Partners Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $121k 21k 5.67
2023-09-30 $134k 23k 5.76
2023-06-30 $119k 23k 5.15
2023-03-31 $87k 20k 4.44
2022-12-31 $91k 19k 4.67

More positions owned by Financial Partners Group

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr S&p 100 Etf (OEF)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Proshares Tr S&p 500 Dv Arist (NOBL)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Apple (AAPL)
First Tr Exchange Trad Fd Vi FST TR GLB FD (FTGC)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Core S&p Ttl Stk (ITOT)
Spdr Ser Tr Bloomberg Sht Te (SJNK)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
American Centy Etf Tr Avantis Core Fi (AVIG)
Cambria Etf Tr Shshld Yield Etf (SYLD)
Fidelity Covington Trust Msci Info Tech I (FTEC)
Microsoft Corporation (MSFT)

View all positions for Financial Partners Group

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Nomura Holdings
Cambridge Investment Research Advisors
Thomas J. Herzfeld Advisors
Saba Capital Management
Wagner Wealth Management
Penserra Capital Management
Advisor Group Holdings
H D Vest Advisory Services
Rockefeller Capital Management
Royal Bank of Canada
Kestra Advisory Services
Ellis Investment Partners
Prime Capital Investment Advisors
Feltz Wealth PLAN

View all funds holding Fs Global Cr Opportunitie Fda